Hatlevoll, R <br/><br/>
Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.  [electronic resource] 

 -  Cancer  Jul 1985 
 - 41-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19850701)56:1<41::aid-cncr2820560108>3.0.co;2-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Adult<br/>Aged<br/>Brain Neoplasms--drug therapy<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Lomustine--adverse effects<br/>Male<br/>Middle Aged<br/>Misonidazole--adverse effects<br/>Nitroimidazoles--therapeutic use<br/>Radiotherapy Dosage<br/>Random Allocation<br/>Scandinavian and Nordic Countries<br/>Telencephalon--surgery